All News

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Findings from a recently published study demonstrated that only a small percentage of women — all with breast cancer — who received silicone breast implants underwent the recommended screening to assess for potential ruptures.

Despite how caring they may be, certain people in our life had a difficult time being there for the realities of my daughter’s cancer experience.

Treatment with primary radiotherapy was linked to an increased risk for the development of secondary primary cancers among a large group of men with localized prostate cancer, according to recent study findings.

The findings add to a growing body of literature that demonstrate coffee and/or tea consumption is not detrimental to breast cancer survivors, according to the study authors.

Losing my hair from breast cancer treatments was an emotional experience for me and helped me empathize with others who also lost their hair.

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

Cancer treatment-related osteoporosis caused me to shrink two inches.

Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.

The FDA will allow the study of CYAD-101, a novel CAR-T cell therapy, to continue in patients with metastatic colorectal cancer now that the eligibility criteria for the trial has been amended.

Shrinking liver cancer tumors helps patients become eligible for transplant, thus improving their long-term outcomes, according to recent study results.

After being diagnosed with cancer, hope can be a very fragile thing, but it is essential that we hold on to it.

TAVT-45, an easy-to-swallow drug that can be suspended in water or juice, is being studied for the treatment of patients with metastatic prostate cancer.

In honor of World Lung Cancer Day, CURE® compiled the five most-read lung cancer-related news items from 2022 that patients may have missed.

I felt her authenticity and her genuine care for me. I felt safe.

Findings from the CheckMate-914 trial showed that Opdivo plus Yervoy did not meet the study’s main goal of disease-free survival for patients with localized renal cell carcinoma, a type of kidney cancer.

I don’t fit the profile of someone who gets diagnosed with mesothelioma, so my diagnosis came as a shock.

From actors Tony Dow and David Warner dying from cancer to a cancer survivor rappelling a building in the name of awareness and fundraising, here’s what’s happening in the oncology space this week.

Watch Dr. Ravi Salgia, Dr. Erminia Massarelli, Dr. Jyoti Malhotra and Daniel Saez answer questions about advancements in lung cancer during the CURE Educated Patient Lung Cancer Summit.

Treatment with Opdivo plus standard of care chemotherapy followed by maintenance Opdivo or Opdivo plus Yervoy failed to elicit survival benefits compared with standard of care chemotherapy alone in patients with previously untreated advanced biliary cancer, which is a rare form of liver cancer.

Although some advancements to boost minority and female enrollment onto cancer clinical trials have occurred since the passing of a law 20 years ago, those improvements have begun to level off, according to an expert.

After being a 20-year brain tumor survivor, I met with a genetic counselor and learned that I have a MUYTH gene mutation.

I was feeling fatigued after undergoing breast cancer treatment, but once I started walking multiple times a week, I noticed that I felt much better.

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

A new treatment group within the PYNNACLE clinical trial is set to evaluate a novel drug plus Keytruda in patients with p53 Y220C-mutant locally advanced or metastatic solid tumors.

With society entrenched in an “infodemic,” it can be challenging for many patients with cancer to identify what information online is accurate. Recently, the development of a new tool may help patients decipher what news is misleading.

Drawing helped me stay grounded while my wife was going through cancer treatment.

More than half of patients with metastatic, cisplatin-ineligible bladder cancer saw their cancer shrink when given Padcev and Keytruda in a clinical trial.

Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer.